Analyst
TD Cowen
Equibles does not estimate personal net worth.
Joshua Jennings is recorded as Analyst at TD Cowen. Joshua Jennings has spoken on 31 earnings calls and 6 other investor events across 20 companies, most recently for Edap Tms SA on September 15, 2026. Those appearances were for Edap Tms SA (FOCL), Butterfly Network, Inc. (BFLY), Dexcom Inc (DXCM), Pulse Biosciences, Inc. (PLSE), Boston Scientific Corp (BSX) and 15 other companies. The companies whose calls Joshua Jennings spoke on are classified in the Healthcare sector.
“Wanted to just ask about one of your slides, Ryan, where you talked about, I think, ablation being less than 10% of localized prostate cancer interventions today going to 40%. and it seemed like most of the share gains are assumed between surgery and radiation.”
“Wanted to just ask about one of your slides, Ryan, where you talked about, I think, ablation being less than 10% of localized prostate cancer interventions today going to 40%. and it seemed like most of the share gains are assumed between surgery and radiation.”
“I wanted to just ask about the procedural efficiency you're seeing in the IDE study. The protocol, I think, is general anesthesia for each patient. So it sounds like from your download, and I would imagine that physicians are having aha moments as they're doing six, seven cases in one day.”
“Wanted to start with a question on IFC, you know, excellent performance off of the most challenging comp of the year on a revenue dollar basis. BCA seems to be helping with the momentum there here in 2026.”
TD Cowen
Analyst
Source not stated
FOCL
Medical Distribution · Healthcare
DXCM
Medical Devices · Healthcare
Medical Instruments & Supplies · Healthcare
CBLL
Medical Devices · Healthcare
CERS
Medical Devices · Healthcare
Medical Instruments & Supplies · Healthcare
MDT
Medical Devices · Healthcare
MDWD
Biotechnology · Healthcare
HUMA
Biotechnology · Healthcare
Medical Instruments & Supplies · Healthcare
RCEL
Medical Devices · Healthcare
VCEL
Biotechnology · Healthcare
